Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Application 2026-05-26
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Etanercept, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract T 2026-05-26
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Ranibizumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract 2026-05-26
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Tocilizumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract 2026-05-26
Germany Volume Contract Switches Region East 2027 And 2028 2026-05-26
Germany The 2: Delivery Orders 2026-05-26
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Ustekinumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract 2026-05-26
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Eculizumab 2026-05-26
Germany Device For Two-photon Polymerization 2026-05-26
Germany Support Of The Social Authority In The Development Of The Property At Repsoldstr. 27 And Accompanying Communication Measures 2026-05-26
Whats app